Successful treatment of recurrent pediatric inflammatory myofibroblastic tumor in a single patient with a novel chemotherapeutic regimen containing celecoxib.
Kevin Johnson, David M Notrica, David Carpentieri, Dawn Jaroszewski, Michael M Henry
Index: J. Pediatr. Hematol. Oncol. 35(5) , 414-6, (2013)
Full Text: HTML
Abstract
Inflammatory myofibroblastic tumors are rare tumors characterized as low-to-intermediate grade sarcomas. This is a case of a 7-year-old male with a 5-cm lung mass, which recurred 11 months after complete resection. The recurrence manifested as multifocal metastatic disease involving the ipsilateral parietal and visceral pleura. A novel chemotherapeutic regimen, which included vincristine, ifosfamide, doxorubicin, and celecoxib was utilized for the disease recurrence. The patient had complete and durable remission of the disease and has been disease-free for >4 years. This novel regimen including a cyclooxygenase 2 inhibitor may be an effective regimen for metastatic inflammatory myofibroblastic tumors.
Related Compounds
Related Articles:
2014-12-01
[Eur. J. Cancer 50(18) , 3243-61, (2014)]
2015-02-01
[Mol. Cell Biochem. 400(1-2) , 41-50, (2015)]
2014-12-01
[Biochim. Biophys. Acta 1841(12) , 1672-82, (2015)]
2015-02-01
[Fundam. Clin. Pharmacol. 29(1) , 62-71, (2015)]
2014-12-01
[Eur. J. Nutr. 53(8) , 1645-57, (2014)]